Skip to main content
letter
. 2022 Sep 2;12(9):125. doi: 10.1038/s41408-022-00723-4

Fig. 1. Best observed response in patients with diffuse large B-cell lymphoma treated with R-CEOP and R-CHOP.

Fig. 1

Stacked bar graph depicting best response showing no significant difference in overall response in patients treated with RCEOPas compared to patients treated with R-CHOP (p = 0.15).